A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
Genentech, Inc.
National Cancer Institute (NCI)
Eli Lilly and Company
Regor Pharmaceuticals Inc.
OncoC4, Inc.
Kortuc, Inc.
Seagen Inc.
KaliVir Immunotherapeutics
Arcus Biosciences, Inc.
Radiopharm Theranostics, Ltd
Sotio Biotech Inc.
Eli Lilly and Company
SystImmune Inc.
Rondo Therapeutics
M.D. Anderson Cancer Center
Orano Med LLC
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Alterome Therapeutics, Inc.
Sutro Biopharma, Inc.
ViroMissile, Inc.
AbbVie
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
Institute of Cancer Research, United Kingdom
Jonsson Comprehensive Cancer Center
MacroGenics
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SystImmune Inc.
Pheon Therapeutics
Xinqiao Hospital of Chongqing
Tongji Hospital
Eli Lilly and Company
Fusion Pharmaceuticals Inc.
Innate Pharma
Dren Bio
Memorial Sloan Kettering Cancer Center
OncoNano Medicine, Inc.
City of Hope Medical Center
Risen (Suzhou) Pharma Tech Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Therorna
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)